Dydrogesterone support following assisted reproductive technique (ART) reduces the risk of pre-eclampsia
-
Anizah Bt Ali
Abstract
Background:
Pre-eclampsia (PE) contributes to poor maternal morbidity and mortality. Progesterone is hypothesised to reduce the risk of PE.
Aim:
To determine the effect of progestogen supplementation during assisted reproductive technique (ART) in reducing the incidence of PE.
Method:
A retrospective comparative analysis among 1140 pregnancies between January 2006 and March 2015 conducted in a tertiary centre. A total of 570 pregnancies who conceived following ART with progesterone supplementation (study group) and an age-matched spontaneous pregnancies, without progesterone supplementation (control group, n=570) were included in the analysis. The study group received progesterone support following ART or intrauterine insemination (IUI) until 14–16 weeks’ gestation.
Results:
The rate of PE was significantly lower in the study group compared to control group (8.4% vs. 14.2%, p<0.05). Women supplemented with dydrogesterone only showed a lower PE incidence as compared to women received a combination of dydrogesterone and hydroxyprogesterone caproate, however, it was not statistically significant (6.9% vs. 9.9%; 6.9%; p=0.2).
Acknowledgments
The research team would like to thank all the staff in the Medically Assisted Conception Centre (MAC), labour room and the Universiti Kebangsaan Malaysia Medical Centre for their co-operation during the data collection process. We declare no conflict of interest. This study was not funded.
Ethical approval: This is to certify that prior ethical approval was obtained from the Research and Ethical Committee, Faculty of Medicine, Universiti Kebangsaan Malaysia before the study was commenced with a ethic number of FF-2015-345.
References
1. Noraihan MN, Sharda P, Jammal AB. Report of 50 Cases of Eclampsia. J Obstet Gynaecol Res 2005;31:302–9.10.1111/j.1447-0756.2005.00292.xSuche in Google Scholar PubMed
2. Dolea C, Carla A. Global burden of hypertensive disorders of pregnancy in the year 2000. Global Burden of Disease 2000, 2003.Suche in Google Scholar
3. Duley L. Pre-eclampsia and the hypertensive disorders of pregnancy. Brit Med Bull 2003;67:161–76.10.1093/bmb/ldg005Suche in Google Scholar PubMed
4. Wallis AB, Saftlas AF, Hsia J, Atrash HK. Secular trends in the rates of preeclampsia, eclampsia, and gestational hypertension, United States, 1987–2004. Am J Hypertens 2008;21:521–6.10.1038/ajh.2008.20Suche in Google Scholar PubMed
5. Woldringh GH, Frunt MH, Kremer JA, Spaanderman ME. Decreased ovarian reserve relates to pre-eclampsia in IVF/ICSI pregnancies. Hum Reprod 2006;21:2948–54.10.1093/humrep/del155Suche in Google Scholar PubMed
6. Pijnenborg R, Anthony J, Davey DA, Rees A, Tiltman A, Vercruysse L, Assche A. Placental bed spiral arteries in the hypertensive disorders of pregnancy. Br J Obstet Gynaecol 1991;98:648–55.10.1111/j.1471-0528.1991.tb13450.xSuche in Google Scholar PubMed
7. Huppertz B. Placental origins of preeclampsia challenging the current hypothesis. Hypertension 2008;51:970–5.10.1161/HYPERTENSIONAHA.107.107607Suche in Google Scholar PubMed
8. Leeman LF. Hypertensive disorders of pregnancy. Am Fam Physician 2008;78:93–100.Suche in Google Scholar
9. Zainul Rashid MR, Lim JF, Nawawi NH, Luqman M, Zolkeplai MF, Rangkuty HS, Mohamad Nor NA, Tamil A, Shah SA, Tham SW, Schindler AE. A pilot study to determine whether progestogen supplementation using dydrogesterone during the first trimester will reduce the incidence of gestational hypertension in primigravidae. Gynecol Endocrinol 2014;30:217–20.10.3109/09513590.2013.860960Suche in Google Scholar PubMed
10. Pandian RU. Dydrogesterone in threatened miscarriage: a Malaysian experience. Maturitas 2009;65:S47–50.10.1016/j.maturitas.2009.11.016Suche in Google Scholar PubMed
11. Sammour MB, el-Kabarity H, Fawzy MM, Schindler AE. Prevention and treatment of pregnancy-induced hypertension (preeclampsia) with progestogens. J Steroid Biochem Mol Biol 2005;97:439–40.10.1016/j.jsbmb.2005.08.014Suche in Google Scholar PubMed
12. Kiprono LV, Wallace K, Moseley J, Martin J Jr, Lamarca B. Progesterone blunts vascular endothelial cell secretion of endothelin-1 in response to placental ischemia. Am J Obstet Gynecol 2013;209:44. e1–6.10.1016/j.ajog.2013.03.032Suche in Google Scholar PubMed PubMed Central
13. Boschitsch E, Mayerhofer S, Magometschnigg D. Hypertension in women: the role of progesterone and aldosterone. Climateric 2010;13:307–13.10.3109/13697131003624649Suche in Google Scholar
14. Chakravarty BN, Shirazee HH, Dam P, Goswami SK, Chatterjee R, Ghosh S. Oral dydrogesterone versus intravaginal micronised progesterone as luteal phase support in assisted reproductive technology (ART) cycles: Results of a randomised study. J Steroid Biochem Mol Biol 2005;97:416–20.10.1016/j.jsbmb.2005.08.012Suche in Google Scholar
15. Ludwig M, Schwartz P, Babahana B, Katalinic A, Weiss JM, Felberbaum R, Al-Hasani S, Diedric K. Luteal phase support using either Crinone® 8% or Utrogest®: results of a prospective, randomized study. Eur J Obstet Gynecol Reprod Biol 2002;103:48–52.10.1016/S0301-2115(02)00010-6Suche in Google Scholar
16. Ludwig M, Finas A, Katalinic A, Strik D, Kowalcek I, Schwartz P, Felberbaum R, Kupker K, Schopper B, Al-Hasani S, Diedrich K. Prospective, randomized study to evaluate the success rates using hCG, vaginal progesterone or a combination of both for luteal phasesupport. Acta Obstet Gynecol Scand 2001;80:574–82.10.1034/j.1600-0412.2001.080006574.xSuche in Google Scholar
17. Apantaku O, Chandrasekaran I, Bentick B. Obstetric outcome of singleton pregnancies achieved with in vitro fertilisation and intracytoplasmic sperm injection: Experience from a district general hospital. J Obstet Gynaecol 2008;28:398–402.10.1080/01443610802091792Suche in Google Scholar PubMed
18. Chaveeva P, Chaveeva P, Syngelaki A, Akolekar R, Nicolaides KH. Contribution of method of conception on pregnancy outcome after the 11–13 weeks scan. Fetal Diagn Ther 2011;30:9–22.10.1159/000323921Suche in Google Scholar PubMed
19. Miyake H, Iwasaki N, Nakai A, Suzuki S, Takeshita T. The influence of assisted reproductive technology on women with pregnancy-induced hypertension: a retrospective study at a Japanese Regional Perinatal Center. J Nippon Med Sch 2010;77:312–7.10.1272/jnms.77.312Suche in Google Scholar PubMed
20. Meher S, Duley L. Progesterone for preventing pre-eclampsia and its complications. Cochrane Database Syst Rev 2006;4:CD006175.10.1002/14651858.CD006175Suche in Google Scholar PubMed PubMed Central
©2016 Walter de Gruyter GmbH, Berlin/Boston
Artikel in diesem Heft
- Frontmatter
- Mini-Review Article
- Dydrogesterone and pre-term birth
- Case Reports
- Successful prevention of preeclampsia in a high-risk pregnancy using progestogen dydrogesterone: a clinical case
- Use of hydroxyprogesterone caproate to prevent preterm labour in uterine didelphys: a case report
- Original Articles
- Dydrogesterone support following assisted reproductive technique (ART) reduces the risk of pre-eclampsia
- Maternal obesity is associated with a low serum progesterone level in early pregnancy
Artikel in diesem Heft
- Frontmatter
- Mini-Review Article
- Dydrogesterone and pre-term birth
- Case Reports
- Successful prevention of preeclampsia in a high-risk pregnancy using progestogen dydrogesterone: a clinical case
- Use of hydroxyprogesterone caproate to prevent preterm labour in uterine didelphys: a case report
- Original Articles
- Dydrogesterone support following assisted reproductive technique (ART) reduces the risk of pre-eclampsia
- Maternal obesity is associated with a low serum progesterone level in early pregnancy
